CDMO Profile

ExcellGene SA

ExcellGene SA Contract Manufacturing & Development (CDMO) Profile

Leading provider of GMP-ready CHO and HEK293 cell lines and production processes for scalable manufacturing of antibodies, fusion proteins, biosimilars, vaccines and viral vectors. Over 20 years experience, family owned, Swiss based.

CDMO Services:
Biologics; Cell & Gene Therapy Analytical Development; Cell Line Development; Process Development; Protein Synthesis Antibodies; Fusion Proteins; Recombinants + other Proteins; Protein Vaccines

Year Founded: 2001

Head Office: Monthey, Switzerland

Number of Facilities: 1-2

Facility locations: Europe

Website: Visit the ExcellGene SA website

Linkedin: Connect on Linkedin

Current Capacity: We have free capacity to take on new business.

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.